Oncotarget · 2017 · 25 citations · 27 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionLaryngeal CancerMalignant NeoplasmsMetastatic Signaling PathwaysOncogenic Signaling PathwaysLaryngeal Squamous Cell CarcinomaOncogenic Signaling NetworksPhosphatidylinositol 3-Kinase-akt PathwayPi3k-akt Signaling PathwaySignalingTrkb SignalingTumor Metastasis BiologyWestern Blot Analysis
// Liang Jiang 1, 2 , Zhihai Wang 1 , Chuan Liu 1 , Zhitao Gong 1 , Yucheng Yang 1 , Houyong Kang 1 , Yanshi Li 1 and Guohua Hu 1 1 Department of Otolaryngology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016 China 2 Department of Otolaryngology Head and Neck Surgery, Affiliated Hospital of Southwest Medical University, Luzhou, 646000 China Correspondence to: Guohua Hu, email: guohuahu@sohu.com Keywords: TrkB; laryngeal cancer; PI3K/AKT pathway; tumorigenicity Received: May 17, 2017     Accepted: August 17, 2017     Published: October 09, 2017 ABSTRACT Objectives: The aim of our study was to investigate the role of TrkB pathway in tumor occurrence and development for in order to provide theoretical basis to laryngeal cancer therapy. Materials and methods: Biological characteristics of the cells were studied by migration tests and colony forming assay. Gene and protein expression analysis was performed by RT-PCR or western blot. in vivo experiments were conducted in syngeneic BALB/c mice. Results: Significant changes in protein and gene expression, including higher expression level of TrkB, were found in cells and laryngeal cancer specimens. we demonstrated that TrkB activates AKT via c-Src, leading to increased proliferation. Also, TrkB induced EMT via increased expression of EMT related transcription factors such as Twist-1 and Twist-2. Conclusion: Our data indicate TrkB are overexpressed in laryngeal cancer, and TrkB signaling is involved in tumorigenicity of laryngeal cancer. These observations suggest that TrkB is a promising target for future intervention strategies to prevent tumor metastasis, EMT program in laryngeal cancer. What is already known about this subject? • Cancer of the larynx is one of the most common types of head and neck cancer. • The survival rate of advanced laryngeal cancer is only 30 to 40%. • The tropomyosin-related kinase B receptor (TrkB), together with TrkA and TrkC, are neurotrophin receptors regulating the proliferation and differentiation of neuronal cells. What are the new findings? • TrkB are overexpressed in laryngeal cancer. • TrkB signaling is involved in tumorigenicity of laryngeal cancer. • TrkB acts as a key regulator of the PI3K/AKT signal pathway-mediated tumor metastasis. How might these results change the focus of research or clinical practice? • These observations suggest that TrkB is a promising target for future intervention strategies to prevent tumor metastasis, EMT program in laryngeal cancer. Our study provides molecular insight into the tumor metastasis and has important implications in elucidating oncogenic processes.
27
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma
Michael E. Kupferman, Tilahun Jiffar, Adel K. El‐Naggar et al. · Oncogene · 2010 · 192 citations · Full text
Medicine, Cell Biology, Oncology +14
Jun Song, Insoon Chang, Zhuo Chen et al. · PLoS ONE · 2010 · 146 citations · Full text
Medicine, Cell Biology, Oncology +17